Cardiometabolic risk markers

2 papers

Humans1

Latest

13 in 12 months

Annals of Medicine and Surgery13 Oct

Advances in pharmacologic management of obesity: oral semaglutide for weight management

ReviewSemaglutide

Food & Function29 Sep

Development and evaluation of oat β-glucan enriched white wheat bread: physicochemical properties, sensory acceptance and effects on cardiometabolic risk markers in mildly hypercholesterolemic subjects with overweight/obesity

Non-randomised trial in peopleHypercholesterolemia

Pilot and Feasibility Studies26 Sep

FOR-HEALTH: study protocol for a randomized controlled feasibility trial of Structured Health Dialogues to improve lifestyle habits and metabolic health in forensic psychiatric inpatients

Study protocolInterventions

GeroScience24 Sep

Frailty trajectories and cardiovascular disease in adults with CKM stages 0-3

Cohort study of 4,219 peopleCardiovascular disease

Endocrinology, Diabetes & Metabolism16 Sep

Impact of Semaglutide, Liraglutide and Tirzepatide on Cardiometabolic Outcomes: A Comparative Narrative Review

ReviewLiraglutide

Nutrients15 Sep

Whole Grain Oats and Barley Products Modify Lipoproteins and Cardiometabolic Risk Markers in Adults: A 6-Week, Double-Blind, Parallel Design, Randomized Controlled Feeding Trial

Randomised trial in 68 peopleInterventions

Frontiers in Physiology13 Sep

Acute and chronic effects of cumulative vs. continuous physical activity on cardiovascular metabolic risk biomarkers in adults: a systematic review and meta-analysis

Meta-analysisInterventions

Frontiers in Endocrinology11 Sep

Effectiveness of community-based Baduanjin combined with resistance training on cardiometabolic risk factors in older adults with type 2 diabetes: a 16-week randomized controlled trial

Randomised trial in 123 peopleType 2 diabetes

Diabetes, Obesity & Metabolism7 Jul

Real-World Effectiveness and Safety of Tirzepatide in Type 1 Diabetes and Obesity: Impact on Glycaemia, Weight, and Cardiometabolic Risk Markers

Cohort study in peopleTirzepatide

ADA Scientific Sessions 2026 Abstract5 Jun

Fibrosis-4 Index Is Associated with ASCVD Burden, MACE, and Mortality in Real-World Type 2 Diabetes Cohort

Cohort study of 8,900 peopleFibrosis-4 Index